ADAR1 Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

ADAR1 Capital Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$636K	Buy	21,278 +16,202	+319%	+$473K	0.04%	190
2025 Q4	$147K	Buy	+5,076	New	+$102K	0.01%	236
2025 Q2	–	Sell	-1,408	Closed	-$111K	–	238
2025 Q1	$111K	Buy	+1,408	New	+$173K	0.02%	161
2024 Q4	–	Sell	-3,057	Closed	-$287K	–	304
2024 Q3	$287K	Sell	3,057 -367	-11%	-$34.8K	0.05%	146
2024 Q2	$337K	Buy	3,424 +1,222	+55%	+$152K	0.06%	118
2024 Q1	$338K	Buy	+2,202	New	+$237K	0.08%	97

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ADAR1 Capital Management's YARW Position: Q1 2026 in Review

ADAR1 Capital Management increased its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 319% in Q1 2026, buying an estimated $473K and bringing the position to 21,278 shares worth $636K. The position accounts for 0.04% of the portfolio, ranked #190.

ADAR1 Capital Management first reported a position in YARW in Q1 2024 and has held it in 6 quarters since. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

ADAR1 Capital Management held 21,278 shares of Yarrow Bioscience, Inc. Common Stock worth $636K as of Q1 2026.
ADAR1 Capital Management bought 16,202 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $473K.
Yarrow Bioscience, Inc. Common Stock made up 0.04% of ADAR1 Capital Management's portfolio in Q1 2026, its #190 holding.
ADAR1 Capital Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2024 and has held it in 6 quarters since.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.